Therapeutic RNA molecules, including antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), short hairpin RNAs (shRNAs), microRNAs (miRNAs), and long intergenic non-coding RNA (lncRNAs), have been developed for STAT3-targeted lung cancer therapy. Here, STAT3 is linked to lung carcinoma.